MicroRNA-patterns in breast cancer patients

by Luger, Pia
State: New
$31.99
VAT included - FREE Shipping
Luger, Pia MicroRNA-patterns in breast cancer patients
Luger, Pia - MicroRNA-patterns in breast cancer patients

Do you like this product? Spread the word!

$31.99 incl. VAT
Only 1 items available Only 1 items available
Delivery: between Tuesday, September 28, 2021 and Thursday, September 30, 2021
Sales & Shipping: Dodax

Check other buying options

1 Offer for $31.99

Sold by Dodax EU

$31.99 incl. VAT
State: New
Free Shipping
Delivery: between Tuesday, September 28, 2021 and Thursday, September 30, 2021
View other buying options

Description

Radiotherapy plus boost to the tumor bed is part of the standard treatment for early stage breast cancer. To deliver the boost by means of intraoperative radiotherapy with electrons (IOERT) is biologically twice as effective as the conventional percutaneous method. A number of prognostic and predictive markers have been described for local control, disease free and overall survival.Recently miRs, which are short non-coding RNAs, were discovered as potential predictors and prognosticators for breast cancer. As opposed to other RNA molecules, miRs are very stable and can therefore be investigated a long time after the tissue sample has been taken. miRNA 375 seems to play an important role in the development and recurrence of breast cancer and should be explored in further studies.

Contributors

Author:
Luger, Pia

Further information

Biography Artist:
Pia Luger, BSc, MSc: Bachelor study genetic at the Faculty of Natural Science at the Paris Lodron University of Salzburg, Master study biology at the Faculty of Natural Science at the Paris Lodron University of Salzburg
Language:
English
Number of Pages:
68
Media Type:
Softcover
Publisher:
AV Akademikerverlag

Master Data

Product Type:
Paperback book
Package Dimensions:
0.229 x 0.152 x 0.004 m; 0.108 kg
GTIN:
09783639843781
DUIN:
SK2UACKE66F
$31.99
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.